1,468
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Oral roflumilast as a therapeutic option for psoriasis, what role does it have? Case report and literature review

, , &
Article: 2240456 | Received 23 May 2023, Accepted 19 Jul 2023, Published online: 25 Jul 2023
 

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

Data sharing not applicable – no new data generated.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.